Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 2 days · Every feed →

All 21Congress 0Executive branch 0Insiders 21
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

RYTM · Insiders · $50K+ · 21 trades

Trades
21
Buys 0 · Sells 21
People
7
Stocks
1
Disclosed value
$32.5M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$3.1Mdisclosed Sep 14 · filed the same day
  2. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$655Kdisclosed Sep 14 · filed the same day
  3. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$242Kdisclosed Sep 14 · filed the same day
  4. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$190Kdisclosed Sep 14 · filed the same day
  5. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$900Kdisclosed Sep 14 · filed the same day
  6. ▼ SELLHunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.$3Mdisclosed Sep 1 · filed 1 day after the trade
  7. ▼ SELLHunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.$2.4Mdisclosed Sep 1 · filed 1 day after the trade
  8. ▼ SELLHunter C Smith Chief Financial OfficerRYTM Rhythm Pharmaceuticals, Inc.$1.2Mdisclosed Sep 1 · filed 1 day after the trade
  9. ▼ SELLAlastair Garfield Chief Scientific OfficerRYTM Rhythm Pharmaceuticals, Inc.$95.3Kdisclosed Aug 17 · filed 4 days after the trade
  10. ▼ SELLAlastair Garfield Chief Scientific OfficerRYTM Rhythm Pharmaceuticals, Inc.$233Kdisclosed Aug 17 · filed 4 days after the trade
  11. ▼ SELLJoseph Shulman Chief Technical OfficerRYTM Rhythm Pharmaceuticals, Inc.$608Kdisclosed Aug 17 · filed 4 days after the trade
  12. ▼ SELLAlastair Garfield Chief Scientific OfficerRYTM Rhythm Pharmaceuticals, Inc.$182Kdisclosed Aug 17 · filed 4 days after the trade
  13. ▼ SELLAlastair Garfield Chief Scientific OfficerRYTM Rhythm Pharmaceuticals, Inc.$402Kdisclosed Aug 17 · filed 4 days after the trade
  14. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$413Kdisclosed Aug 14 · filed 2 days after the trade
  15. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$257Kdisclosed Aug 14 · filed 2 days after the trade
  16. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$2Mdisclosed Aug 14 · filed 2 days after the trade
  17. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$113Kdisclosed Aug 14 · filed 2 days after the trade
  18. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$1.7Mdisclosed Aug 14 · filed 2 days after the trade
  19. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$2.1Mdisclosed Aug 14 · filed 2 days after the trade
  20. ▼ SELLJennifer Kayden Lee EVP, Head of North AmericaRYTM Rhythm Pharmaceuticals, Inc.$8.9Mdisclosed Aug 14 · filed 1 day after the trade
  21. ▼ SELLLynn A. Tetrault DirectorRYTM Rhythm Pharmaceuticals, Inc.$3.7Mdisclosed Jun 24 · filed 2 days after the trade